{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:13:43Z","timestamp":1777540423981,"version":"3.51.4"},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1507\/endocrj.ej15-0577","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T22:22:59Z","timestamp":1453933379000},"page":"375-380","source":"Crossref","is-referenced-by-count":25,"title":["Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto&amp;rsquo;s disease"],"prefix":"10.1507","volume":"63","author":[{"given":"Tomoya","family":"Kagawa","sequence":"first","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Otsu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minori","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukina","family":"Takuse","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Iwatani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Volpe R (2001) The immune system and its role in endocrine function. In: Becker KL (ed) Principles and Practice of Endocrinology and Metabolism. Lippincott Williams &amp; Wilkins, Philadelphia: 1770-1781."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Morshed SA, Latif R, Davies TF (2012) Delineating the autoimmune mechanisms in Graves&rsquo; disease. <i>Immunol Res<\/i> 54: 191-203.","DOI":"10.1007\/s12026-012-8312-8"},{"key":"3","unstructured":"3. Weetman AP (2013) The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. <i>Eur Thyroid J<\/i> 1: 243-250."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Inoue N, Watanabe M, Wada M, Morita M, Hidaka Y, <i>et al<\/i>. (2013) IL-10 -592A\/C polymorphism is associated with severity of Hashimoto&rsquo;s disease. <i>Cytokine<\/i> 64: 370-374.","DOI":"10.1016\/j.cyto.2013.05.014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Inoue N, Watanabe M, Morita M, Tatusmi K, Hidaka Y, <i>et al<\/i>. (2011) Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases. <i>Clin Exp Immunol<\/i> 163: 318-323.","DOI":"10.1111\/j.1365-2249.2010.04306.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hayashi F, Watanabe M, Nanba T, Inoue N, Akamizu T, <i>et al<\/i>. (2009) Association of -31C\/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves&rsquo; disease and the proportion of Th17 cells. <i>Clin Exp Immunol<\/i> 158: 281-286.","DOI":"10.1111\/j.1365-2249.2009.04034.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nanba T, Watanabe M, Akamizu T, Iwatani Y (2008) The -590CC genotype in interleukin-4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto&rsquo;s disease. <i>Clin Chem<\/i> 54: 621-623.","DOI":"10.1373\/clinchem.2007.099739"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y (2006) Association between the severity of Hashimoto&rsquo;s disease and the functional +874A\/T polymorphism in the interferon-gamma gene. <i>Endocr J<\/i> 53: 473-478.","DOI":"10.1507\/endocrj.K06-015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y (2008) The 869T\/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. <i>Clin Exp Immunol<\/i> 151: 379-382.","DOI":"10.1111\/j.1365-2249.2007.03575.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. <i>Cell <\/i>116: 281-297.","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. <i>Nat Rev Immunol<\/i> 8: 120-130.","DOI":"10.1038\/nri2252"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. <i>Cell<\/i> 120: 15-20.","DOI":"10.1016\/j.cell.2004.12.035"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Baltimore D, Boldin MP, O&rsquo;Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. <i>Nat Immunol<\/i> 9: 839-845.","DOI":"10.1038\/ni.f.209"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Qu Z, Li W, Fu B (2014) MicroRNAs in autoimmune diseases. <i>Biomed Res Int<\/i> 2014: 527895.","DOI":"10.1155\/2014\/527895"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bernecker C, Halim F, Lenz L, Haase M, Nguyen T, <i>et al<\/i>. (2014) microRNA expressions in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases. <i>Exp Clin Endocrinol Diabetes<\/i> 122: 107-112.","DOI":"10.1055\/s-0033-1361088"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamada H, Itoh M, Hiratsuka I, Hashimoto S (2014) Circulating microRNAs in autoimmune thyroid diseases. <i>Clin Endocrinol (Oxf)<\/i> 81: 276-281.","DOI":"10.1111\/cen.12432"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Inoue Y, Watanabe M, Inoue N, Kagawa T, Shibutani S, <i>et al<\/i>. (2014) Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases. <i>Clin Exp Immunol<\/i> 178: 229-235.","DOI":"10.1111\/cei.12410"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, <i>et al<\/i>. (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. <i>Nature <\/i>408: 86-89.","DOI":"10.1038\/35040556"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Swaminathan S, Suzuki K, Seddiki N, Kaplan W, Cowley MJ, <i>et al<\/i>. (2012) Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression. <i>J Immunol<\/i> 188: 6238-6246.","DOI":"10.4049\/jimmunol.1101196"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Jiang L, Cheng Z, Qiu S, Que Z, Bao W, <i>et al<\/i>. (2012) Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells. <i>Int Immunopharmacol<\/i> 14: 217-223.","DOI":"10.1016\/j.intimp.2012.07.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Guan H, Fan D, Mrelashvili D, Hao H, Singh NP, <i>et al<\/i>. (2013) MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. <i>Eur J Immunol<\/i> 43: 104-114.","DOI":"10.1002\/eji.201242702"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK (2001) Type 1 T regulatory cells. <i>Immunol Rev<\/i> 182: 68-79.","DOI":"10.1034\/j.1600-065X.2001.1820105.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Moore KW, de Waal Malefyt R, Coffman RL, O&rsquo;Garra A (2001) Interleukin-10 and the interleukin-10 receptor. <i>Annu Rev Immunol<\/i> 19: 683-765.","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Saraiva M, O&rsquo;Garra A (2010) The regulation of IL-10 production by immune cells. <i>Nat Rev Immunol<\/i> 10: 170-181.","DOI":"10.1038\/nri2711"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, <i>et al<\/i>. (2004) Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto&rsquo;s thyroiditis (Th1) and Graves&rsquo; disease (Th2). <i>Neuroimmunomodulation <\/i>11: 209-213.","DOI":"10.1159\/000078438"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Don&iacute;z-Padilla L, Paniagua AE, Sandoval-Correa P, Monsiv&aacute;is-Urenda A, Leskela S, <i>et al<\/i>. (2011) Analysis of expression and function of the inhibitory receptor ILT2 in lymphocytes from patients with autoimmune thyroid disease. <i>Eur J Endocrinol <\/i>165: 129-136.","DOI":"10.1530\/EJE-11-0109"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chen WF, Zlotnik A (1991) IL-10: a novel cytotoxic T cell differentiation factor. <i>J Immunol<\/i> 147: 528-534.","DOI":"10.4049\/jimmunol.147.2.528"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Groux H, Bigler M, de Vries JE, Roncarolo MG (1998) Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. <i>J Immunol<\/i> 160: 3188-3193.","DOI":"10.4049\/jimmunol.160.7.3188"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, <i>et al<\/i>. (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren&rsquo;s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. <i>Arthritis Rheum<\/i> 37: 1647-1655.","DOI":"10.1002\/art.1780371114"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, <i>et al<\/i>. (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W F1 mice. <i>J Exp Med<\/i> 179: 305-310.","DOI":"10.1084\/jem.179.1.305"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wogensen L, Lee MS, Sarvetnick N (1994) Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. <i>J Exp Med<\/i> 179: 1379-1384.","DOI":"10.1084\/jem.179.4.1379"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Balasa B, Sarvetnick N (1998) Cytokines and IDDM: implications for etiology and therapy. <i>Drug News Perspect<\/i> 11: 356-360.","DOI":"10.1358\/dnp.1998.11.6.863657"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0577\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:55:51Z","timestamp":1692204951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/63\/4\/63_EJ15-0577\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej15-0577","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}